Literature DB >> 9311916

Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene.

H Shibata1, K Toyama, H Shioya, M Ito, M Hirota, S Hasegawa, H Matsumoto, H Takano, T Akiyama, K Toyoshima, R Kanamaru, Y Kanegae, I Saito, Y Nakamura, K Shiba, T Noda.   

Abstract

Familial adenomatous polyposis coli (FAP) is a disease characterized by the development of multiple colorectal adenomas, and affected individuals carry germline mutations in the APC gene. With the use of a conditional gene targeting system, a mouse model of FAP was created that circumvents the embryonic lethality of Apc deficiency and directs Apc inactivation specifically to the colorectal epithelium. loxP sites were inserted into the introns around Apc exon 14, and the resultant mutant allele (Apc580S) was introduced into the mouse germline. Mice homozygous for Apc580S were normal; however, upon infection of the colorectal region with an adenovirus encoding the Cre recombinase, the mice developed adenomas within 4 weeks. The adenomas showed deletion of Apc exon 14, indicating that the loss of Apc function was caused by Cre-loxP-mediated recombination.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311916     DOI: 10.1126/science.278.5335.120

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  220 in total

1.  Efficient gene activation in cultured mammalian cells mediated by FLP recombinase-expressing recombinant adenovirus.

Authors:  M Nakano; K Odaka; M Ishimura; S Kondo; N Tachikawa; J Chiba; Y Kanegae; I Saito
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

2.  Epithelial stem cell repertoire in the gut: clues to the origin of cell lineages, proliferative units and cancer.

Authors:  N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

3.  Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonic epithelial proliferation.

Authors:  Kris A Steinbrecher; Steve A Wowk; Jeffrey A Rudolph; David P Witte; Mitchell B Cohen
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

4.  An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin.

Authors:  M Kitagawa; S Hatakeyama; M Shirane; M Matsumoto; N Ishida; K Hattori; I Nakamichi; A Kikuchi; K Nakayama; K Nakayama
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

5.  Simultaneous on/off regulation of transgenes located on a mammalian chromosome with Cre-expressing adenovirus and a mutant loxP.

Authors:  Saki Kondo; Aya Okuda; Hiromi Sato; Naoto Tachikawa; Miho Terashima; Yumi Kanegae; Izumu Saito
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

6.  Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration.

Authors:  Owen J Sansom; Karen R Reed; Anthony J Hayes; Heather Ireland; Hannah Brinkmann; Ian P Newton; Eduard Batlle; Patricia Simon-Assmann; Hans Clevers; Inke S Nathke; Alan R Clarke; Douglas J Winton
Journal:  Genes Dev       Date:  2004-06-15       Impact factor: 11.361

7.  Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity.

Authors:  Richard Kemp; Heather Ireland; Elizabeth Clayton; Carol Houghton; Louise Howard; Douglas J Winton
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

8.  Localized all-cell knock-out (LACKO) strategy is needed for studying adult stage diseases.

Authors:  Xiaolan Du; Ying Zhu; Fengtao Luo; Lin Chen
Journal:  Transgenic Res       Date:  2012-06-14       Impact factor: 2.788

9.  Genetic and Chemical Models of Colorectal Cancer in Mice.

Authors:  Mandayam O Nandan; Vincent W Yang
Journal:  Curr Colorectal Cancer Rep       Date:  2010-03-10

10.  Molecular imaging reveals a role for AKT in resistance to cisplatin for ovarian endometrioid adenocarcinoma.

Authors:  Hanxiao Wang; Stefanie Galbán; Rong Wu; Brittany M Bowman; Amanda Witte; Katrin Vetter; Craig J Galbán; Brian D Ross; Kathleen R Cho; Alnawaz Rehemtulla
Journal:  Clin Cancer Res       Date:  2012-10-24       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.